Coupled with an infusion of [13C6]glucose, this strategy allowed us to rigorously assess the impact of acute SGLT2 inhibition on systemic metabolism as well as the relative rates of myocardial substrate utilization in healthy rats and rats with heart failure in a fully integrated neurohumoral milieu. This evidence concerns the gene SLC5A2 and heart failure.